These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 9652561)

  • 21. Rotavirus vaccines and vaccination in Latin America.
    Linhares AC; Bresee JS
    Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetravalent human-rhesus reassortant rotavirus vaccine: a review of its immunogenicity, tolerability and protective efficacy against paediatric rotavirus gastroenteritis.
    Foster RH; Wagstaff AJ
    BioDrugs; 1998 Feb; 9(2):155-78. PubMed ID: 18020551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period.
    Armah GE; Kapikian AZ; Vesikari T; Cunliffe N; Jacobson RM; Burlington DB; Ruiz LP
    J Infect Dis; 2013 Aug; 208(3):423-31. PubMed ID: 23599316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.
    Ruiz-Palacios GM; Pérez-Schael I; Velázquez FR; Abate H; Breuer T; Clemens SC; Cheuvart B; Espinoza F; Gillard P; Innis BL; Cervantes Y; Linhares AC; López P; Macías-Parra M; Ortega-Barría E; Richardson V; Rivera-Medina DM; Rivera L; Salinas B; Pavía-Ruz N; Salmerón J; Rüttimann R; Tinoco JC; Rubio P; Nuñez E; Guerrero ML; Yarzábal JP; Damaso S; Tornieporth N; Sáez-Llorens X; Vergara RF; Vesikari T; Bouckenooghe A; Clemens R; De Vos B; O'Ryan M;
    N Engl J Med; 2006 Jan; 354(1):11-22. PubMed ID: 16394298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Ward RL; Mack ME; Zito ET
    J Infect Dis; 1996 Feb; 173(2):306-13. PubMed ID: 8568290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial.
    Bernstein DI; Sack DA; Rothstein E; Reisinger K; Smith VE; O'Sullivan D; Spriggs DR; Ward RL
    Lancet; 1999 Jul; 354(9175):287-90. PubMed ID: 10440305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life.
    Bhandari N; Rongsen-Chandola T; Bavdekar A; John J; Antony K; Taneja S; Goyal N; Kawade A; Kang G; Rathore SS; Juvekar S; Muliyil J; Arya A; Shaikh H; Abraham V; Vrati S; Proschan M; Kohberger R; Thiry G; Glass R; Greenberg HB; Curlin G; Mohan K; Harshavardhan GV; Prasad S; Rao TS; Boslego J; Bhan MK;
    Vaccine; 2014 Aug; 32 Suppl 1():A110-6. PubMed ID: 25091663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.
    Salinas B; Pérez Schael I; Linhares AC; Ruiz Palacios GM; Guerrero ML; Yarzábal JP; Cervantes Y; Costa Clemens S; Damaso S; Hardt K; De Vos B
    Pediatr Infect Dis J; 2005 Sep; 24(9):807-16. PubMed ID: 16148848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
    Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
    Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal administration of rhesus rotavirus tetravalent vaccine.
    Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a pentavalent human-bovine reassortant rotavirus vaccine against rotavirus gastroenteritis among American Indian children.
    Grant LR; Watt JP; Weatherholtz RC; Moulton LH; Reid R; Santosham M; O'Brien KL
    Pediatr Infect Dis J; 2012 Feb; 31(2):184-8. PubMed ID: 22252206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cortese MM; Parashar UD;
    MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants.
    Treanor JJ; Clark HF; Pichichero M; Christy C; Gouvea V; Shrager D; Palazzo S; Offit P
    Pediatr Infect Dis J; 1995 Apr; 14(4):301-7. PubMed ID: 7603812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of safety and immunogenicity of a live attenuated tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus vaccine (BRV-TV) in healthy Indian adults and infants.
    Dhingra MS; Kundu R; Gupta M; Kanungo S; Ganguly N; Singh MP; Bhattacharya MK; Ghosh R; Kumar R; Sur D; Chadha SM; Saluja T
    Vaccine; 2014 Aug; 32 Suppl 1():A117-23. PubMed ID: 25091664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
    Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
    Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ
    Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials of live oral rotavirus vaccines: the Finnish experience.
    Vesikari T
    Vaccine; 1993; 11(2):255-61. PubMed ID: 8382419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.